78815

PET/CT whole body, with delayed imaging

Positron emission tomography (PET) imaging, whole body, from skull base to mid-thigh, where a single static or dynamic acquisition is performed for any anatomical area followed by delayed imaging. Concurrently acquired computed tomography (CT) is used for attenuation correction and anatomical localization. This code specifically includes the performance of delayed imaging, which is often crucial for characterizing lesions or differentiating malignant from benign processes by observing changes in radiopharmaceutical uptake over time, typically hours after initial acquisition.

Clinical Indications

  • Initial staging and restaging of various malignancies (e.g., lung cancer, lymphoma, melanoma, colorectal cancer, head and neck cancer, esophageal cancer, breast cancer) where initial imaging findings are equivocal or require further characterization.
  • Evaluation of suspected tumor recurrence in oncology patients, especially when conventional imaging is inconclusive or tumor markers are rising.
  • Differentiation of post-treatment changes (e.g., inflammation, fibrosis, necrosis) from active residual or recurrent disease.
  • Characterization of indeterminate lesions (e.g., pulmonary nodules, suspicious masses, bone lesions) identified on other imaging modalities, where delayed imaging provides additional metabolic information to guide diagnosis or management.
  • Assessment of therapeutic response to chemotherapy, radiation therapy, or targeted agents, particularly when initial findings are ambiguous or to evaluate treatment-induced metabolic changes.

Procedure Steps

  1. Patient preparation, including fasting (typically 4-6 hours) and blood glucose level verification to ensure optimal FDG uptake.
  2. Intravenous administration of a radiopharmaceutical, most commonly F-18 fluorodeoxyglucose (FDG).
  3. An uptake phase (typically 60-90 minutes) during which the tracer distributes throughout the body and is taken up by metabolically active cells.
  4. Initial PET/CT scan acquisition covering the anatomical region from the skull base to mid-thigh.
  5. A delay period (e.g., 2-3 hours) as per protocol or physician discretion to allow for changes in tracer kinetics.
  6. Performance of a delayed PET/CT scan acquisition over the same anatomical area, often focusing on regions of initial concern.
  7. Image reconstruction, processing, and fusion of PET and CT images for detailed anatomical and metabolic assessment.
  8. Interpretation of the combined PET/CT images by a nuclear medicine physician or radiologist, including comparison of initial and delayed acquisitions.

Coding Guidelines

  • Report CPT code 78815 for whole-body PET/CT from skull base to mid-thigh when delayed imaging is performed as part of the study. This code should not be reported with other PET codes (78811-78814, 78816) for the same service.
  • The CT component performed concurrently for attenuation correction and anatomical localization is integral to the PET/CT procedure and should not be separately coded. If a distinct diagnostic CT study is performed for a separate clinical indication, it may be separately reportable with appropriate documentation.
  • The radiopharmaceutical agent (e.g., A9552 for F-18 FDG) used for the PET study should be reported separately.
  • Documentation must clearly indicate the medical necessity for the whole-body scan and the rationale for performing delayed imaging, as this adds complexity and time to the procedure.
  • This code encompasses both the technical and professional components of the service when performed in a facility setting. Modifiers such as -26 for professional component or -TC for technical component may be appended as appropriate for billing specific services.

Associated ICD-10 Codes